NBY
Novabay Pharmaceuticals Inc
Halal Rating :
Last Price
$0.70
Last updated:
Market Cap
-
7D Change
-7.22%
1 Year Change
349.04%
Company Overview
Industries
Exchange
Next Earnings Date
NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company that develops and commercializes non-antibiotic anti-infective products. The company's main product line includes Avenova, an antimicrobial lid and lash solution, CelleRx Clinical Reset, a facial spray, and NovaWipes. Their products are primarily used for eye care and skincare applications.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $2.44m | $3.65m | - | $151000.0 | 0.00% | 4.13% |
| June 30, 2024 | $2.4m | $3.75m | - | $300000.0 | 0.00% | 7.99% |
| March 31, 2024 | $2.63m | $5.5m | - | $433000.0 | 0.00% | 7.87% |
Company Impact
Help us evaluate Novabay Pharmaceuticals Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.